TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351)-Reference-Cited by-同舟云学术

TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351)

Published:2021-09-03 Issue:1 Volume:9 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Lee Jihye¹,Lee JinAh¹,Kim Hyeon Ju¹,Ko Meehyun¹,Jee Youngmee²,Kim Seungtaek¹

Affiliation:

1. Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam, South Korea

2. CEO office, Institut Pasteur Korea, Seongnam, South Korea

Abstract

The coronavirus disease 2019 (COVID-19) pandemic is causing unprecedented global problems in both public health and human society. While some vaccines and monoclonal antibodies were successfully developed very quickly and are currently being used, numerous variants of the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are emerging and threatening the efficacy of vaccines and monoclonal antibodies.

Funder

National Research Foundation of Korea

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/Spectrum.00472-21

Reference24 articles.

1. A pneumonia outbreak associated with a new coronavirus of probable bat origin

2. SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

3. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19